The short answer: Yes. Mounjaro (tirzepatide) causes some lean mass loss, but the split is similar to other forms of weight loss. In the SURMOUNT-1 DXA substudy, about 75% of the weight lost was fat and about 25% was lean mass, the same ratio seen with placebo. You can limit the lean portion with enough protein (1.2 to 1.6 g per kg of body weight per day in published reviews), resistance training two to three times a week, and a steady rate of weight loss.

What did SURMOUNT-1 show about lean mass on tirzepatide?

The best tirzepatide-specific data come from a body composition substudy of the SURMOUNT-1 trial, published in Diabetes, Obesity and Metabolism in 2025. Of the 2,539 people in SURMOUNT-1, 160 had dual-energy X-ray absorptiometry (DXA) scans at baseline and at week 72. Of those, 124 took tirzepatide (all doses pooled) and 36 took placebo. The group was 73% female, with a mean weight of 102.5 kg and a mean BMI of 38.0.

The results at week 72:

  • Tirzepatide: body weight fell 21.3%, fat mass fell 33.9%, and lean mass fell 10.9%.
  • Placebo: body weight fell 5.3%, fat mass fell 8.2%, and lean mass fell 2.6%.
  • Of the weight lost, roughly 75% was fat mass and 25% was lean mass in both groups.

Post hoc subgroup analyses by sex, age (under 50, 50 to 64, and 65 and older), and amount of weight lost showed the same proportions in most groups. Several authors are Eli Lilly employees, so read it as sponsor-run data. For the headline weight numbers from the full trial, see our Mounjaro weight loss results page.

Two systematic reviews frame the wider evidence. A 2024 review of six randomized trials found clear reductions in fat mass and visceral fat but called the effect on fat-free mass "inconclusive." A 2025 review of imaging-based trials concluded that tirzepatide reduces fat while relatively preserving lean mass, with muscle composition markers stable or improved. The direction is consistent; the exact size of the muscle effect is not settled.

Is muscle loss unique to Mounjaro?

No. Losing lean mass with any large weight loss is expected. A 2014 review in Obesity Reviews traced the "Quarter FFM Rule," the long-standing estimate that about one-fourth of lost weight is fat-free mass. The authors found that lean tissue losses with dieting are usually small, and that age, inactivity, and exercise change the fraction. The SURMOUNT-1 substudy landed almost exactly on that rule.

Two more points matter. First, "lean mass" on a DXA scan is not the same as muscle. It includes water, organs, bone-free connective tissue, and the non-fat part of fat tissue itself. A 2024 paper in the Journal of the Endocrine Society explains that some fat-free mass loss is obligatory when adipose tissue shrinks, because fat tissue contains water and protein too. Second, skeletal muscle is only one part of fat-free mass, so a 10.9% drop in lean mass does not mean 10.9% less muscle.

The same pattern shows up with semaglutide and other GLP-1 drugs. Our sister site covers that in GLP-1 drugs and muscle loss.

Why does losing lean mass matter?

Muscle is what lets you climb stairs, carry groceries, and get up from a chair. Losing it makes those tasks harder. Lean tissue also drives most of your resting energy use. In a randomized trial of 42 adults, the group that lost weight fastest lost more lean body mass and had a larger drop in resting metabolic rate. Fewer calories burned at rest makes weight maintenance harder later.

Older adults have the most to lose. They start with less muscle, and age-related muscle loss is already underway. The SURMOUNT-1 substudy found the same 25% lean fraction in people 65 and older. The same percentage from a smaller starting muscle base costs more function. That is why the prevention steps below matter most after 60.

How much protein should you eat on Mounjaro?

A 2015 review in the American Journal of Clinical Nutrition pooled meta-analyses of energy-restriction diets. Higher-protein diets produced greater fat loss and better preservation of lean mass than lower-protein diets. The authors' range was 1.2 to 1.6 g of protein per kg of body weight per day, with about 25 to 30 g at each meal.

For a 90 kg person, that is 108 to 144 g of protein a day. For a 75 kg person, it is 90 to 120 g. The per-meal target matters because tirzepatide cuts appetite hard. If you can only finish half a plate, make the first half protein: eggs, Greek yogurt, fish, poultry, tofu, beans, or cottage cheese. Our Mounjaro diet plan lays out sample days built around these targets.

People with kidney disease should confirm a protein target with their clinician first.

Does resistance training prevent muscle loss?

This is the most effective tool you have. A 2022 meta-analysis in Obesity Reviews pooled 114 randomized trials with 4,184 participants with overweight or obesity. When resistance training was combined with caloric restriction, lean mass was maintained (about -0.3 kg, not statistically significant) while fat mass fell by 5.3 kg compared with no intervention. Resistance training without dieting added 0.8 kg of lean mass. The results held across age and sex groups.

The evidence is even stronger in older adults. A 2018 meta-analysis of six randomized trials in older adults with obesity found that resistance training three times a week, for 12 to 24 weeks, prevented 93.5% of the lean mass loss caused by calorie restriction. Fat loss was the same with or without training. Strength per kg of lean mass rose 20.9% with training versus a 7.5% drop without it.

Practical takeaways:

  • Lift two to three times a week. The trials above used three sessions.
  • Work the major muscle groups: legs, hips, back, chest, shoulders, and arms.
  • Add weight or reps over time. Muscle only adapts to a load that keeps rising.
  • Bodyweight moves, bands, and machines all count.

Does the pace of weight loss matter?

Yes, though the evidence is smaller. In the 42-person trial above, one group lost 5% of body weight in 5 weeks and the other lost the same 5% over 15 weeks. The fast group lost more lean body mass, fat-free mass, and total body water, and saw a larger drop in resting metabolic rate. The slow group lost more fat and more waist circumference.

The Mounjaro prescribing label starts at 2.5 mg once weekly, moves to 5 mg after 4 weeks, and then allows 2.5 mg steps after at least 4 weeks on each dose, up to 15 mg. The label sets that schedule for tolerability and blood sugar control, not for muscle. Still, the slow ramp means weight loss builds over months, not weeks. Do not change your dose or skip doses to slow things down on your own. If you are eating very little or losing weight faster than you and your prescriber expected, tell them. See our Mounjaro dosing schedule for what the label allows.

Is there a drug to protect muscle on Mounjaro?

Not yet. Eli Lilly is running a Phase 2 trial (NCT06643728) of bimagrumab, an injectable antibody, given alone or with tirzepatide in 252 adults with obesity or overweight and no type 2 diabetes. The study started in October 2024, reached primary completion in January 2026, and lists an estimated completion date of January 2027. The primary outcome is percent change in body weight. As of this writing, ClinicalTrials.gov shows no posted results, and the combination is not approved. Protein, lifting, and pace are the tools that exist now.

The bottom line

Mounjaro causes lean mass loss in about the same proportion as any other weight loss: roughly one-quarter of lost weight in SURMOUNT-1 DXA data. That lean mass is not all muscle, and some of it is unavoidable. The controllable part responds to three things. Eat 1.2 to 1.6 g of protein per kg per day, spread across meals. Do resistance training two to three times a week. Let weight loss build at the pace the label allows instead of chasing speed. In older adults, resistance training alone prevented nearly all diet-driven lean mass loss in trials.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your prescriber before changing your diet, exercise, or Mounjaro dose.